Celltrion gets US FDA approval for new biosimilar for autoimmune disease treatment Seoul, Jan 31: Celltrion, a major South Korean biopharmaceutical firm, on Friday said its new biosimilar for an autoimmune disease treatment has received approval from the US Food and Drug Administrat...
Safdarjung Hospital performs its first-ever (CAR) T-cell therapy to treat certain types of lymphoma and blood cancers New Delhi, January 24: The VMMC and Safdarjung Hospital has successfully performed its first-ever Chimeric Antigen Receptor (CAR) T-cell therapy under the leadership of Prof. Sandeep Bansal (Medical S...
